Stay Updated
For all press requests, please reach out to [email protected].
News and Reports
NBC 5: President Trump says tariffs on pharmaceuticals are coming soon
“One in three people cannot afford to fill their prescription drugs today,” said Patients for Affordable Drugs Executive Director Merith Basey. “There is real concern, understandably, that these tariffs would increase costs for patients and make their lives much harder.”
News and Reports
“Tariffs will exacerbate that problem,” said Merith Basey, Executive Director of the advocacy group Patients For Affordable Drugs. “Prescription drugs aren’t luxury goods; they’re essential to people’s health and survival.”
News and Reports
AXIOS: First look: Trump is urged to keep drug negotiations
A new ad campaign by P4AD asks the administration to maintain Medicare drug price negotiation process.
News and Reports
USA TODAY: Prescription drugs dodge Trump's worldwide tariff for now. What to know
“So many Americans have limited savings,” said Merith Basey, Executive Director at P4AD. “Even what may be perceived as a small increase over a year can be a huge amount for somebody who has a fixed income. Those costs add up.”
News and Reports
IPWatchDog: Patient Group and Trump DOJ Defend Medicare Pricing Program in Third Circuit Briefs
“Novartis has raked in billions of dollars from Entresto while patients are forced to make impossible choices just to afford it…. This lawsuit isn’t about constitutional rights – it’s about corporate greed and preserving massive profits at the expense of patients.” – Merith Basey, P4AD Executive Director
News and Reports
STAT: A bill is re-introduced in Congress to revise provisions in drug-pricing law
“Make no mistake, this is yet another attempt by Big Pharma to rig the system in its favor — at the expense of patients” – Merith Basey, P4AD Executive Director
News and Reports
ProPublica: What a $2 Million Per Dose Gene Therapy Reveals About Drug Pricing
“Drug companies charge whatever they think they can get away with,” said David Mitchell, the founder of Patients For Affordable Drugs. “And every time the benchmark moves up, they think, ‘Well, we can get away with more.’